K192987 is an FDA 510(k) clearance for the Aina HbA1c Monitoring System 2. This device is classified as a Assay, Glycosylated Hemoglobin (Class II - Special Controls, product code LCP).
Submitted by Jana Care, Inc. (Boston, US). The FDA issued a Cleared decision on March 26, 2020, 153 days after receiving the submission on October 25, 2019.
This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 864.7470.
| 510(k) Number | K192987 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | October 25, 2019 |
| Decision Date | March 26, 2020 |
| Days to Decision | 153 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | LCP - Assay, Glycosylated Hemoglobin |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 864.7470 |